 |
 |
 |
 
|
|
 |
||||
 |
||||
|
Latest News May 17, 2010 NA April 17, 2010 NA September 15, 2009 NA September 15, 2009 NA September 15, 2009 NA December 10, 2008 NA September 21, 2008 NA September 21, 2008 NA August 13, 2008 NA April 24, 2007 GalMed raised $2 Million in convertible bonds. The company will use the proceeds to fund preclinical programs of its lead compound Aramchol
|